how glp-1 improve insulin resistance Use of Glucagon-Like Peptide-1 Mechanisms by which GLP-1 agonists

Recently, SGLT2i and GLP1- RAs have emerged as potential therapeutic tools preventing the transition from acute to chronic kidney disease due to their efficacy in preserving renal function

We present the case of a 14-year-old female patient with autism, developmental delay, and obesity managed with semaglutide who presented for esophagogastroduodenoscopy and colonoscopy

More and more evidence is showing that the use of DPP4 Inhibitors and GLP1 Receptor Agonists in combination, is a practice worth changing

In this video, we explore the rising use of GLP-1 drugs like Ozempic and Wegovy, which were initially developed for managing conditions such as type 2 diabetes

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

The Good Kitchen takes the guesswork out of what should I eat? Our rotating menu is chef-crafted and dietitian-approved, designed to support metabolic health with balanced meals that taste great and feel good